Depressive stupor - Malignant neuroleptic syndrome - Serotonin syndrome. A case report illustrating a problem in differential diagnosis;DEPRESSIVER STUPOR - MALIGNES NEUROLEPTISCHES SYNDROM - SEROTONINSYNDROM. EIN KASUISTISCHER BEITRAG ZU EINER SCHWIERIGEN DIFFERENTIALDIAGNOSE

Nervenarzt

Volumn 67, Issue 5, 1996, Pages 407-412

  Konig F ^a   Loble M ^a   Wolfersdorf, M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

combination of antidepressants; MNS; moclobemide; serotonin syndrome; stupor

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BIPERIDEN; GLIBENCLAMIDE; HALOPERIDOL; LORAZEPAM; MAPROTILINE; MELPERONE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PERAZINE; RAMIPRIL; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRIMIPRAMINE;

ADULT; AGITATION; ARTICLE; ATAXIA; CASE REPORT; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; STUPOR; VERTIGO;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BENZAMIDES; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMANS; MIDDLE AGED; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNDROME; TRIMIPRAMINE;

EID: 0029946171     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Aurorix®-Fachinformation (1994) Hoffmann-La Roche AG, Basel
2. Eikmeier G, Berger M, Lodemann E, Muszynski Kaumeier S, Gastpar M (1991) Trimipramine - an atypical neuroleptic? Int Clin Pharmacol 6: 147-153
3. Fröhlich L, Fritze J (1992) Stupor, Katatonie und malignes neuroleptisches Syndrom. In: Riederer PG, Laux W, Pöldinger W (Hrsg) Neuropsychopharmaka, Bd 6 Notfalltherapie - Antiepileptika, Beta-Rezeptorenblocker und sonstige Psychopharmaka. Springer, Wien New York. S 41-50
4. Grosser KD (1987) Die thyreotoxische Krise. Intensivmedizin 24: 8-14
5. Hamilton MS, Opler LA (1992) Akathisia, suicidality and fluoxetine. J Clin Psychiatry 53: 401-406
6. Hetzel W (1992) Safety of moclobemide taken in overdose for attempted suicide. Psychopharmacology 106 [Suppl]: 127-129
7. Heuser J, Benkert O (1986) Lorazepam for a short-term allevation of mutism. J Clin Psychopharmacol 6: 62
8. Insel TR, Roy BF, Cohen RM, Murphy DL (1982) Possible development of the serotonin syndrome in man. Am J Psychiatry 139: 954-955
9. Keck PE, Pope HG, Cohen BM, Mc Elroy SL, Nierenberg AA (1989) Risk factors for neuroleptic malignant syndrome. Arch Gen Psychiatry 46: 914-918
10. König F, Wolfersdorf M, Barg T, Löble M, Leibfarth M, Grünewald I, Wetzel S (1995) Kombinationstherapie von Moclobemid mit tri- und tetrazyklischen Antidepressiva bei therapieresistenter Depression. Nervenheilkunde 14: S 24-S 26
11. König F, Wolfersdorf M, Wößner S, Hauger B, Löble M, Barg T, Kaschka W-P (1995) Combined therapy using moclobemide, trimipramine and maprotiline for therapy resistant depression. Poster presented at 3th International Conference on Refractory Depression. 18-21 October Napa Valley, CA
12. König F, Wolfersdorf M, Hauger B, Barg T, Wößner S, Löble M, (1996) Klinische Erfahrungen mit Moclobemid bei therapieresistenter Depression. Nervenheilkunde (in Druck)
13. Kraepelin F. (1883) Compendium der Psychiatrie. Abel, Leipzig
14. Neuvonen PJ, Pohjota-Suitonen S, Tacke U, Knori E (1993) Five fatal cases of serotonin syndrome after moclobemide-citalopram overdoses. Lancet 342: 1419
15. Nierenberg DW, Semprebon M (1993) The CNS serotonin syndrome. Clin Pharmacol Ther 53: 84-88
16. Peters UH (1990) Wörterbuch der Psychiatrie. Urban & Schwarzenberg, München Wien Baltimore, S 511
17. Piezcker A (1988) Das maligne neuroleptische Syndrom. Nervenarzt 59: 691-700
18. Raja M, Altavista MC, Cavallari S, Lubich L (1994) Neuroleptic malignant syndrome and catatonia. Eur Arch Psychiatry Clin Neurosci 243: 299-303
19. Schoerlin MP, Mayersohn M, Kom A, Eggers M (1987) Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor. Single and multiple dosing in normal subjects. Clin Pharmacol Ther 42: 395-404
20. Staud L, Pflug B (1992) Das maligne neuroleptische Syndrom - ein kasuistischer Beitrag zur Diagnose. Differentialdiagnose und Therapie einer lebensbedrohlichen Komplikation der Behandlung mit Neuroleptika. Psychiatr Prax 19: 114-118
21. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705-713
22. Truong DD, Sczesni B, Fahn S, Gross J, Donovan K, van Bakel A, Wiley M (1988) Das neuroleptische maligne Syndrom (dopaminabhängige maligne Hyperthermie). Nervenarzt 59: 103-109
23. Wetzel H, Heuser J, Benkert O (1987) Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 175: 240-242
24. Wolfersdorf M, König F (1994) Wahnhaft depressive Patienten - zur Diagnostik und Pharmakotherapie bei einer depressiven Problemgruppe. Schweiz Rundsch Med Prax 83: 438-443